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ment of anatomically fixed bowel parts showed good recog-
nition by MRE. With increasing CRP values, we found more 
positive results of ultrasound and MRE. Therapeutic change 
was suggested in only 18 patients.  Conclusions: Ultrasound 
should be performed by an experienced examiner, and a 
proctological examination should be added. MRE is justified 
in cases of discrepancy between clinical findings and the re-
sults of diagnostic ultrasound and, moreover, if Crohn’s le-
sions are suspected at sites proximal to the terminal or neo-
terminal ileum.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Crohn’s disease is a chronic relapsing and remitting 
disorder, presenting as a granulomatous, transmural and 
discontinuous inflammation affecting the wall of the 
gastrointestinal tract. Although the inflammation can 
occur everywhere from the mouth to the anus, it particu-
larly involves the terminal ileum and the proximal colon. 
Recently, magnetic resonance enterography (MRE) as 
well as computed tomography enterography (CTE) is be-
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 Abstract 
 Background/Aims: Some suggest MRI to be superior to ul-
trasound in Crohn’s disease. We analyzed how often MR en-
terography (MRE) following a routine ultrasound leads to a 
change in therapeutic decision.  Material and Methods: We 
retrospectively evaluated 47 patients with Crohn’s disease 
undergoing routine ultrasound examination. Actual medical 
history, complete blood count, C-reactive protein (CRP), and 
sonographic findings were assessed independently by two 
specialists who retrospectively provided a therapeutic pro-
posal. Additionally, all patients received MRE. Thereafter, the 
specialists had to provide a new therapeutic concept regard-
ing all the available information.  Results: Evaluation of the 
rectum was not successful by ultrasound, but MRE gave 
good results. Only 1 of 7 abscesses was identified sono-
graphically. Three of the abscesses missed at sonography 
were localized in the perirectal/perianal region. MRE detect-
ed more inflamed bowel segments, but ultrasound assess-
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ing accepted more and more as the first-line modality for 
the evaluation of suspected inflammatory bowel disease 
 [1–5] . Ultrasound as a widely available, non-radiation ex-
amination can be performed for assessment of bowel wall 
abnormalities and complications of Crohn’s disease such 
as fistulas and abscesses  [6, 7] . Due to increased vascular-
ization in inflammation, an enhanced Doppler signal can 
be found; however, these changes in wall vascularity vi-
sualized by Doppler techniques  [4, 8, 9] show no clear 
correlation with clinical or biological scores  [6, 10] . Some 
suggest MRE to be superior to ultrasound, particularly 
regarding the localization of affected bowel segments and 
the detection of fistulas  [11] . Other studies showed a good 
comparability between the results of MR enterography 
and ultrasound  [12–14] .
 It has to be kept in mind that in all these studies ultra-
sound was performed by a very experienced examiner 
being engaged only with the object of the study and not 
being subjected to any time pressure regarding the ex-
amination. The aim of our study was to analyze in how 
many cases a MRE compared with a routine ultrasound 
done in an interdisciplinary center of clinical ultrasound 
(3 examiners, 60–80 ultrasound examinations a day) 
during normal working time without any special condi-
tions leads to a change in a therapeutic decision. In other 
words, how good is ultrasound under ‘real working con-
ditions’ and what are the implications?
 Material and Methods 
 We retrospectively evaluated findings of MRE and ultrasound 
in 47 in- and outpatients (21 males, 26 females, mean age 31.8  8 
11.4 years) with previously diagnosed Crohn’s disease who under-
went ultrasound as well as MRE. Routine B-scan and Doppler 
ultrasound were performed with a linear 7.5-MHz transducer 
(Elegra, Siemens, Germany; Logiq 9, General Electric, USA) car-
ried out  by one of three examiners in our interdisciplinary center 
of clinical ultrasound (60–80 ultrasound examinations a day) 
during working time (08.00 until 17.00 h) without any special 
conditions. Bowel wall thickening ( 1 3 mm) with hyperperfusion 
to a greater or lesser extent suggested affection by Crohn’s disease. 
Additionally, all patients received MRE in the ‘dark lumen’ tech-
nique as described elsewhere  [15] . Image evaluation was per-
formed by two experienced radiologists in consensus by means of 
bowel wall thickening and increased contrast uptake of the bowel 
wall. The examiners were blinded to the results of the other imag-
ing modality. Delay between the two examinations was 5.8  8 7.0 
days in all 47 patients. Thereafter, actual medical history, com-
plete blood count, C-reactive protein (CRP) and sonographic B-
scan findings were independently assessed by two board-certified 
physicians with extended experience in the diagnosis and therapy 
of Crohn’s disease. No relevant therapeutic actions, such as ad-
ministration of high dose steroids or anti-TNF agents, were taken 
between the performances of ultrasound and MRE, respectively. 
Based on these examinations, the two specialists retrospectively 
provided a therapeutic concept. Thereafter, the physicians were 
additionally given the results of the MRE, and they had to provide 
a new proposal of therapy regarding all the information available 
(current medical history, complete blood count, CRP (normal val-
ue  ! 5 mg/l), results of B-scan ultrasound with Doppler and re-
sults of MRE). Considering the results of MRE, possible criteria 
for a change in therapeutic proposal were a change in the feature 
‘localization’ of the Montreal classification (L1 ileal, L2 colonic, 
L3 ileocolonic, L4 isolated upper gastrointestinal tract, L4 + L1/
L2/L3 upper and L1/L2/L3) and a newly diagnosed abscess. Re-
garding these criteria, one has to keep in mind that – due to in-
formation about clinical presentation and preexisting therapy – 
not every additional information from MRE leads to another 
therapeutic proposal. Since neither a transrectal ultrasound nor a 
magnetic resonance imaging of the pelvis – each the method of 
choice for the detection of pararectal fistulas – were performed in 
our study, we did not regard pararectal fistulas. The ethics com-
mittee at the University of Regensburg approved the study.
 Results 
 Ultrasound Findings and Their Correlation with the 
Results of the MR Examinations 
 Sonographically, the most frequent affected bowel 
segments were found in the ileum and the terminal ile-
um – representing the preferential site of Crohn’s disease. 
17 of 19 findings in the ileum were confirmed by MRE. 
The right and the left colon were the second most fre-
quent affected sites, and MRE could reproduce all sono-
graphic findings in these segments. The only case of in-
flammation of the jejunum detected by ultrasound was 
not confirmed by MRE. Ultrasound did not identify any 
inflammation of the rectum in the 47 patients. In one 
case, sonographic findings showed an abscess ( fig. 1 ).
 Correlation of MRE Assessment with Ultrasound 
Findings of the Corresponding Sites 
 Affection of the ileum was seen 31 times by MRE; 
however, only 17 cases of them could also be identified by 
ultrasound. Ultrasound could not detect any of the jeju-
nal segments affected according to MRE (0/3), further-
more, no rectal (0/7) affection. Seven abscesses were di-
agnosed by MRE, but only one abscess was seen by ultra-
sound ( fig. 2 ). Six patients suffering from abscesses had 
clearly elevated inflammation markers (CRP  1 50 mg/l), 
but only 1 of them presented with fever. The seventh pa-
tient had no fever, but showed a CRP value of only 30.69 
mg/l; however, the abscess was only about 1 cm in size 
(see below).
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 Correlation of Imaging Results with CRP Levels 
 With increasing CRP values, we observed an increas-
ing number of positive ultrasounds and positive MREs. 
Two patients with a CRP value  1 70 mg/l and no evidence 
of a manifestation of Crohn’s disease at MRE and bowel 
ultrasound suffered from pancreatitis while taking aza-
thioprine, and urosepsis with underlying nephrolithiasis, 
respectively. The third patient with normal ultrasound 
and CRP  1 70 mg/l showed an ileitis and an abscess on 
MRE.
 In contrast, there were 6 patients with unremarkable 
CRP values, but positive findings in MR examinations. 
These patients were treated with high-dose systemic cor-
ticosteroids (n = 2), budesonide (n = 1), azathioprine plus 
budesonide (n = 1) or azathioprine plus steroids (n = 1), 
and certolizumab (n = 1), respectively ( fig. 3 ). No abscess-
es were detected with CRP levels below 20 mg/l; the on-
ly 2 patients with CRP  ! 70 mg/dl and an abscess had
CRP values of 58.53 mg/l (with methotrexate) and 30.69 
mg/l (without immunosuppressive therapy), respectively 
( fig. 4 ). However, the latter abscess was only about 1 cm 
in size. Three of the abscesses missed by sonography were 
localized in the pararectal or the perianal region, and one 
further abscess was seen to be only about 1 cm in size at 
MRI.
 Change of Known Bowel Involvement Pattern as a 
Consequence of MRE Findings 
 Since therapeutic implications may arise from a change 
in knowledge of the pattern of bowel involvement, we
analyzed this in our patients. In 24 cases, additional in-
formation from MR examinations resulted in a relevant 
change in the knowledge of affected bowel segments fol-
lowed by a change of placement according to the Mon-
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 Fig. 1. Ultrasound findings and their recognition by MRE.  Fig. 2. MRE and ultrasound findings of the corresponding sites. 
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Table 1. C hange of L classification according to the Montreal clas-
sification 
Classification by 
means of ultrasound
Change as a consequence of MRE results
L1 L3 in 6 cases 
L4 + L1 in 1 case
L2 L1 in 1 case 
L3 in 2 cases 
L4 + L3 in 1 case 
L3 L2 in 1 case 
L4 L1 in 1 case 
No findings L1 in 9 cases 
L2 in 2 cases 
L = Localization.
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treal classification ( table 1 ). In 7 cases, rectal involvement 
was not detected by transabdominal ultrasound but by 
MRE.
 Therapeutic Implications Arising from MR 
Examinations  
 The initial interobserver variability was calculated. 
There was an observed interobserver agreement of 89% 
with   = 0.76 representing a substantial agreement be-
tween the specialists. The specialists discussed the 5 cas-
es in which their assessment differed and reached agree-
ment regarding their therapeutic proposals. Thus, in 18 
of the total 47 patients (38%), a change in therapeutic 
strategy was necessary based on the findings of MR ex-
aminations. Ultrasound was negative concerning Crohn’s 
lesions 11 times, despite clinical findings suggestive of 
activity (e.g. pain, diarrhea), but MRE demonstrated 
bowel inflammation. An abscess found by MRE led to 
another therapeutic approach 4 times, and MRE diag-
nosed a more extended bowel involvement with Crohn’s 
disease affecting either more or other bowel segments 
than ultrasound, causing a change in treatment strategy 
3 times. 
 Discussion 
 Due to its characteristic as a chronic remitting and re-
lapsing disease, patients with Crohn’s disease again and 
again suffer from diarrhea and abdominal pain. These 
complaints are not always caused by bowel inflamma-
tion, but can also be based on Crohn’s disease-associated 
affections such as (drug-induced) pancreatitis (azathio-
prine) or other non-Crohn’s disease-related illnesses such 
as infectious gastroenteritis, nontropical sprue, urinary 
tract infection, gynecological disorders, and many more. 
Thus, besides clinical examinations and laboratory tests, 
patients with Crohn’s disease often have to undergo sev-
eral imaging studies in order to find the most suitable 
therapeutic approach. Ultrasound and MRE are the diag-
nostic imaging techniques of choice in the mostly young 
Crohn’s disease patients since they are not associated 
with the exposure to irradiation, particularly as they are 
noninvasive. 
 Bowel wall ultrasound is an elegant method for clini-
cal follow-up in patients with Crohn’s disease. But it is 
known to have some limitations; thus, Schober et al.  [16] 
recommend that ultrasound should be supplemented in 
both the primary diagnosis and follow-up with methods 
such as endoscopy and complementary imaging.
 The reported ranges of ultrasound sensitivity and 
specificity for the diagnosis of Crohn’s disease are 75–94 
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 Fig. 3. Imaging results and CRP levels.  Fig. 4. Abscesses and CRP levels. 
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and 67–100%, respectively  [17] ; the values of MRI sensi-
tivity and specificity for the diagnosis of Crohn’s disease-
related lesions range from 78 to 100% for both  [18, 19] .
 A number of studies have been done comparing ultra-
sound and MRE with divergent results. Some studies 
showed a good comparability between the results of MRE 
and ultrasound, in some ultrasound was even superior 
 [12–14, 20] . Others suggested that MRE was superior to 
ultrasound, particularly regarding the localization of af-
fected bowel segments and the detection of fistulas  [11] . 
 Similar to the results of Pascu et al.  [13] , evaluation of 
the rectum was not successful using ultrasound, whereas 
assessment by MRE was uncomplicated. Moreover, in 
our study, MRE detected far more inflamed bowel seg-
ments than did ultrasound. However, ultrasound assess-
ment of the anatomically fixed bowel parts such as the 
terminal ileum and left colon showed good recognition 
by MRE, suggesting a good reliability of sonographically 
detected pathological findings of these bowel regions. 
Similar results were presented by Potthast et al.  [11] who 
showed bowel wall ultrasound to have a high sensitivity 
(85%) for recognizing involvement of the terminal or
neoterminal ileum and a significantly lower sensitivity 
(50%) for the evaluation of more proximal bowel seg-
ments. They attributed their findings to the fact that to-
pographic orientation proximal to the terminal or neo-
terminal ileum is difficult with ultrasound.
 We found an increasing number of positive ultra-
sounds and MR examinations with increasing CRP val-
ues. On the other hand, there were 2 patients who com-
plained of abdominal pain with a CRP value  1 70 mg/l 
who had no evidence of manifestation of Crohn’s disease, 
but suffered from other diseases (pancreatitis and uro-
sepsis based on nephrolithiasis). Also, there were 6 pa-
tients with unremarkable CRP values, but positive find-
ings in MRE. All of these patients were treated with im-
munosuppressive drugs. Thus, we can conclude that CRP 
may provide an indication of an acute episode of Crohn’s 
disease, but other causes have to be considered. Further-
more, patients on immunosuppressive drugs can suffer 
from an acute episode of Crohn’s disease or abscess de-
spite normal CRP values. 
 In our collective, we only found seven abscesses at 
MRE, and only one of them could be identified at ultra-
sound. Three of the six abscesses which were not detected 
by sonography were found in the perirectal/perianal re-
gion. Obviously, this region is difficult to assess reliably 
by transabdominal sonography; however, a transrectal 
sonography might have captured these three perirectal/
perianal abscesses. A further abscess was only about 1 cm 
in size. Hence, the markedly good specificity (92–94%) 
and sensitivity (87–100%) of ultrasound in the detection 
of abscesses reported by Potthast et al.  [11] , Maconi et al. 
 [21] and Gasche et al.  [22] can hardly refer to pararectal 
abscesses. In about half (n = 24) of our patients, a change 
in the knowledge of the involvement pattern was evident 
after MRE, this led to a change in therapeutic strategy as 
suggested by the specialists in only 16 of these patients. 
Overall, in 18 patients, the specialists provided a thera-
peutic change, the reason being – besides the above-men-
tioned change of the involvement pattern – the detection 
of abscesses in 4 cases (in 2 patients double finding of in-
volvement pattern and abscess). However, MRE revealed 
rectal involvement in 7 patients, none of which were iden-
tified by ultrasound. The rectal involvement led to a 
change in the Montreal classification in 4 patients and to 
a change of therapeutic strategy proposed by the special-
ists in 3 patients. Thus, if transabdominal ultrasound 
would have been supplemented by proctoscopy, addition-
al information from MRE concerning the involvement 
pattern (Montreal classification) could be assumed in on-
ly 22 patients, and a change of therapeutic proposal due 
to this additional information would have been made in 
only 14 patients. Moreover, if additional transrectal so-
nography would have been performed, the three perirec-
tal/perianal abscesses could have been identified. 
 A limitation of our study is the lack of a reference stan-
dard and, hence, the validation of the ultrasound and 
MRE findings, respectively. Conventional enteroclysis 
and endoscopy represent the Goldstandard for diagno -
sis and evaluation of Crohn’s disease concerning intralu-
minal changes; however, assessment of the transmural
or extramural extent or extraintestinal complications is 
limited. Laparotomy as reference standard for extralumi-
nal manifestations was not performed. Further studies 
comparing the capabilities of bowel wall ultrasound and 
MRE by using a reference standard will be required to 
confirm the findings of the present study.
 Based on our results, we suggest – similar to Potthast 
et al.  [11] – the following procedure in the assessment of 
bowel involvement in Crohn’s disease: ultrasound should 
be performed by an experienced examiner, but in any 
case, a proctological examination should be added. MRE 
is justified in cases of discrepancy between clinical find-
ings and/or laboratory tests and the results of diagnostic 
ultrasound. Magnetic resonance imaging is also useful in 
the diagnosis of intra-abdominal abscesses. Finally, MRE 
should be performed if Crohn’s lesions are suspected at 
sites proximal to the terminal or neoterminal ileum.
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